Literature DB >> 17179267

Levetiracetam reduces anesthetic-induced hyperalgesia in rats.

David P Archer1, Yves Lamberty, Bing Wang, Melinda J Davis, Naaznin Samanani, Sheldon H Roth.   

Abstract

BACKGROUND: As part of an increase in excitability, small doses of pentobarbital, propofol, and midazolam induce an increased sensitivity to pain. Specific therapy to prevent or reduce this excitability may offer advantages over current clinical management with analgesics and sedatives. The pharmacological profile of the novel antiepileptic drug, levetiracetam, suggests that it may reduce the intensity of the excitatory stages of anesthesia.
METHODS: We examined the influence of levetiracetam on the reduction of the nociceptive reflex threshold in rats by sedative doses of pentobarbital, propofol, and midazolam. Measurements of nociceptive reflex threshold to pressure and heat were made and then repeated after intraperitoneal injection of saline or one of three doses of levetiracetam (100, 200, 500 mg/kg). Pentobarbital (30 mg/kg), propofol (30 mg/kg), or midazolam (1.9 mg/kg) were then administered. The reflex threshold was measured every 10 min, starting at 5 min after the sedative injection, until 65 min had elapsed.
RESULTS: Levetiracetam did not alter nociceptive reflex threshold in nonsedated animals (P = 0.11) or influence the degree or duration of sedation. The three anesthetic/sedative drugs reduced the nociceptive reflex threshold by 20%-30% of control values. Levetiracetam reduced the hyperreflexia associated with pentobarbital and midazolam (P < 0.05), but not propofol.
CONCLUSIONS: These findings support further investigation into the role of levetiracetam in the prevention of anesthetic-induced excitability.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17179267     DOI: 10.1213/01.ane.0000247788.57318.1f

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  5 in total

1.  The antihyperalgesic effect of levetiracetam in an inflammatory model of pain in rats: mechanism of action.

Authors:  A Micov; M Tomić; B Popović; R Stepanović-Petrović
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

Review 2.  Painful and involuntary multiple sclerosis.

Authors:  Francesca Bagnato; Diego Centonze; Simonetta Galgani; Maria Grazia Grasso; Shalom Haggiag; Stefano Strano
Journal:  Expert Opin Pharmacother       Date:  2011-02-17       Impact factor: 3.889

3.  Intracerebroventricular Application of Dexmedetomidine Produces Antinociception and Does not Cause Neurotoxicity in Rats.

Authors:  Ersin Köksal; Deniz Karakaya; Bilge Can; Ayhan Bozkurt; Sibel Barış; Süleyman Sırrı Bilge; Yasemin Burcu Ustün
Journal:  Balkan Med J       Date:  2013-12-01       Impact factor: 2.021

4.  Evaluation of antinociceptive and neurotoxic effects of intrathecal dexmedetomidine in rats.

Authors:  Ozgü Işgüzar; Sibel Barış; Ayhan Bozkurt; Bilge Can; Sırrı Bilge; Hatice Türe
Journal:  Balkan Med J       Date:  2012-12-01       Impact factor: 2.021

Review 5.  Current Status of the New Antiepileptic Drugs in Chronic Pain.

Authors:  Harpreet S Sidhu; Akshay Sadhotra
Journal:  Front Pharmacol       Date:  2016-08-25       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.